Early and sustained altered expression of aging-related genes in young 3xTg-AD mice

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Gatta, V ^a,b   D'Aurora, M ^a,b   Granzotto, A ^b   Stuppia, L ^a,b   Sensi, S L ^b,c  

^a Center of Excellence on Aging (CeSI)   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; Alzheimer's disease; inflammation; microarray; mitochondria; synaptic plasticity

Indexed keywords

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APP GENE; ARTICLE; AUTOPHAGY; CALCIUM CELL LEVEL; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DOWN REGULATION; GENE; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; HOMEOSTASIS; INFLAMMATION; MEMORY; MOUSE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PS1 GENE; TAU GENE; UPREGULATION;

AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESENILIN-1; REPRODUCIBILITY OF RESULTS; TAU PROTEINS; TIME FACTORS;

EID: 84896798747     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.11     Document Type: Article

References (62)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. New Eng J Med 2010; 362: 329-344.
2. Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol 2013; 9: 25-34.
3. Herrup K. Reimagining Alzheimer's disease-An age-based hypothesis. J Neurosci 2010 16755-16762.
4. Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2: 1-10.
5. Reddy PH, McWeeney S. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol Aging 2006; 27: 1060-1077.
6. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al. Triple-Transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409-421.
7. Corona C, Pensalfini A, Frazzini V, Sensi SL. New therapeutic targets in Alzheimer's disease: Brain deregulation of calcium and zinc. Cell Death Dis 2011; 2: E176.
8. Ketelaars SO, Gorter JA, Aronica E, Wadman WJ. Calcium extrusion protein expression in the hippocampal formation of chronic epileptic rats after kainate-induced status epilepticus. Epilepsia 2004; 45: 1189-1201.
9. Jin K, Mao XO, Eshoo MW, Nagayama T, Minami M, Simon RP et al. Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol 2001; 50: 93-103.
10. Chakroborty S, Kim J, Schneider C, Jacobson C, Molgo J, Stutzmann GE. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice. J Neurosci 2012; 32: 8341-8353.
11. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795.
12. Pedrola L, Espert A, Wu X, Claramunt R, Shy ME, Palau F. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet 2005; 14: 1087-1094.
13. Miyamae Y, Han J, Sasaki K, Terakawa M, Isoda H, Shigemori H. 3,4,5-Tri-O-caffeoylquinic acid inhibits amyloid beta-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH. Cytotechnology 2011; 63: 191-200.
14. Brickley K, Stephenson FA. Trafficking kinesin protein (TRAK)-mediated transport of mitochondria in axons of hippocampal neurons. J Biol Chem 2011; 286: 18079-18092.
15. Zhang Z, Kageyama Y, Sesaki H. Mitochondrial division prevents neurodegeneration. Autophagy 2012; 8: 1531-1533.
16. Ownby RL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep 2010; 12: 39-45.
17. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493: 674-678.
18. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K et al. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 2013; 78: 631-643.
19. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-791.
20. Mitchell JC, Ariff BB, Yates DM, Lau KF, Perkinton MS, Rogelj B et al. X11beta rescues memory and long-Term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. Hum Mol Genet 2009; 18: 4492-4500.
21. Kaur G, Levy E. Cystatin C in Alzheimer's disease. Front Mol Neurosci 2012; 5: 79.
22. Haberman RP, Quigley CK, Gallagher M. Characterization of CpG island DNA methylation of impairment-related genes in a rat model of cognitive aging. Epigenetics 2012; 7 1019.
23. Nizzari M, Venezia V, Repetto E, Caorsi V, Magrassi R, Gagliani MC et al. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling. J Biol Chem 2007; 282: 13833-13844.
24. Giovannini MG, Cerbai F, Bellucci A, Melani C, Grossi C, Bartolozzi C et al. Differential activation of mitogen-Activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease. Neuroscience 2008; 153 633.
25. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006; 281: 20315-20325.
26. Maki M, Matsukawa N, Yuasa H, Otsuka Y, Yamamoto T, Akatsu H et al. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J Neuropathol Exp Neurol 2002; 61: 176-185.
27. Landgraf I, Muhlhans J, Dedek K, Reim K, Brandstatter JH, Ammermuller J. The absence of Complexin 3 and Complexin 4 differentially impacts the ON and OFF pathways in mouse retina. Eur J Neurosci 2012; 36: 2470-2481.
28. Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R et al. Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging 2012; 33 877.
29. Kim MH, Choi J, Yang J, Chung W, Kim JH, Paik SK et al. Enhanced NMDA receptormediated synaptic transmission, enhanced long-Term potentiation, and impaired learning and memory in mice lacking IRSp53. J Neurosci 2009; 29: 1586-1595.
30. Corona C, Masciopinto F, Silvestri E, Viscovo AD, Lattanzio R, Sorda RL et al. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis 2010; 1: E91.
31. Sheffler-Collins SI, Dalva MB. EphBs: An integral link between synaptic function and synaptopathies. Trends Neurosci 2012; 35: 293-304.
32. Yousef GM, Kishi T, Diamandis EP. Role of kallikrein enzymes in the central nervous system. Clin Chim Acta 2003; 329: 1-8.
33. Shapiro LA, Bialowas-McGoey LA,Whitaker-Azmitia PM. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer's disease: Studies in an S100B overexpressing mouse model. Cardiovasc Psychiatry Neurol 2010; 2010: 1-13.
34. Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle. J Alzheimers Dis 2002; 4: 249-254.
35. Nixon RA, Yang DS. Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb Perspect Biol 2012; 4: 10.
36. Gomez Ravetti M, Rosso OA, Berretta R, Moscato P. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 2010; 5: E10153.
37. Lu Y, Li T, Qureshi HY, Han D, Paudel HK. Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-Associated protein tau in mammalian brain. J Biol Chem 2011; 286: 20569-20581.
38. Yuan H, Zhang P, Qin L, Chen L, Shi S, Lu Y et al. Overexpression of SPINDLIN1 induces cellular senescence, multinucleation and apoptosis. Gene 2008; 410: 67-74.
39. Schwer B, Schumacher B, Lombard DB, Xiao C, Kurtev MV, Gao J et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. Proc Natl Acad Sci USA 2010; 107: 21790-21794.
40. Vakhrusheva O, Braeuer D, Liu Z, Braun T, Bober E. Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging. J Physiol Pharmacol 2008; 59(Suppl 9): 201-212.
41. Majumder S, Richardson A, Strong R, Oddo S. Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One 2011; 6: E25416.
42. Khandelwal PJ, Herman AM, Hoe HS, Rebeck GW, Moussa CE. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Hum Mol Genet 2011; 20: 2091-2102.
43. Ma Q, Qiang J, Gu P, Wang Y, Geng Y, Wang M. Age-related autophagy alterations in the brain of senescence accelerated mouse prone 8 (SAMP8) mice. Exp Gerontol 2011; 46 541.
44. Metcalf DJ, Garcia-Arencibia M, Hochfeld WE, Rubinsztein DC. Autophagy and misfolded proteins in neurodegeneration. Exp Neurol 2012; 238: 22-28.
45. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH et al. Macroautophagy-A novel Beta-Amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171: 87-98.
46. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
47. Tung YT, Wang BJ, Hu MK, Hsu WM, Lee H, Huang WP et al. Autophagy: A double-edged sword in Alzheimer's disease. J Biosci 2012; 37: 157-165.
48. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998; 18 2807.
49. VanGuilder HD, Yan H, Farley JA, Sonntag WE, Freeman WM. Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J Neurochem 2010; 113: 1577-1588.
50. Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA 2012; 109: 10071-10076.
51. Ando K, Uemura K, Kuzuya A, Maesako M, Asada-Utsugi M, Kubota M et al. N-cadherin regulates p38 MAPK signaling via association with JNK-Associated leucine zipper protein: Implications for neurodegeneration in Alzheimer disease. J Biol Chem 2011; 286 7628.
52. Nadif Kasri N, Nakano-Kobayashi A, Malinow R, Li B, Van Aelst L. The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev 2009; 23: 1289-1302.
53. Choi J, Ko J, Racz B, Burette A, Lee JR, Kim S et al. Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases. J Neurosci 2005; 25: 869-879.
54. Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport 2001; 12: 2747-2751.
55. Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, Town T. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia 2010; 58: 300-314.
56. Bialowas-McGoey LA, Lesicka A, Whitaker-Azmitia PM. Vitamin E increases S100B-mediated microglial activation in an S100B-overexpressing mouse model of pathological aging. Glia 2008; 56: 1780-1790.
57. Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L et al. The S100B protein in biological fluids: More than a lifelong biomarker of brain distress. J Neurochem 2012; 120: 644-659.
58. Parisiadou L, Bethani I, Michaki V, Krousti K, Rapti G, Efthimiopoulos S. Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production. Neurobiol Dis 2008; 30: 353-364.
59. Galvin JE, Palamand D, Strider J, Milone M, Pestronk A. The muscle protein dysferlin accumulates in the Alzheimer brain. Acta Neuropathol 2006; 112: 665-671.
60. Podtelezhnikov AA, Tanis KQ, Nebozhyn M, Ray WJ, Stone DJ, Loboda AP. Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One 2011; 6: E29610.
61. Saetre P, Jazin E, Emilsson L. Age-related changes in gene expression are accelerated in Alzheimer's disease. Synapse 2011; 65: 971-974.
62. Cooper-Knock J, Kirby J, Ferraiuolo L, Heath PR, Rattray M, Shaw PJ. Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol 2012; 8: 518-530.